United Kingdom (UK) Diabetes Care Devices Market Size (2024 - 2029)

The United Kingdom diabetes care devices market is projected to experience growth over the forecast period, driven by factors such as the increasing incidence of diabetes, heightened healthcare expenditure, and the impact of the COVID-19 pandemic. The pandemic has accelerated the adoption of remote care and diabetes technology, removing regulatory barriers and expanding market opportunities. Additionally, the rising prevalence of diabetes, influenced by obesity and sedentary lifestyles, underscores the growing demand for diabetes care products, contributing to the market's expansion.

Market Size of United Kingdom (UK) Diabetes Care Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
United Kingdom (UK) Diabetes Care Devices Market Summary
Study Period 2018 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 84.31 Million
Market Size (2029) USD 116.32 Million
CAGR (2024 - 2029) 6.72 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

UK Diabetes Devices Market Analysis

The United Kingdom Diabetes Care Devices Market size is estimated at USD 84.31 million in 2024, and is expected to reach USD 116.32 million by 2029, growing at a CAGR of 6.72% during the forecast period (2024-2029).

The COVID-19 pandemic had a substantial impact on the United Kingdom's diabetes care devices. According to The British Diabetic Association, 'The pandemic has had, and continues to have, a huge impact on our society. However research and data have shown that people with diabetes have been disproportionately affected by COVID-19, particularly in terms of poorer outcomes when contracting the virus. That's why preventing or delaying cases of type 2 diabetes is more important than ever before.'

The pandemic also highlighted opportunities for continuing and expanding innovations in the delivery of diabetes care, through virtual consultations between healthcare providers and people with diabetes, and the use of diabetes technology. Crisis management has created unprecedented interest in remote care from both patients and providers and removed many long-standing regulatory barriers. Thus, the COVID-19 outbreak increased the diabetes care device market's growth.

The rate of newly diagnosed cases of Type 1 and Type 2 diabetes is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care products. According to The British Diabetic Association, Diabetes prevalence 2021 data shows an increase in the number of people living with a diabetes diagnosis in the UK: an increase of more than 150,000 from 2020. It is estimated that more than 13.6 million people are at increased risk of type 2 diabetes in the UK. At this rate, the number of people with diabetes, including the undiagnosed population, is expected to rise to 5.5 million by 2030.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

UK Diabetes Devices Industry Segmentation

Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The United Kingdom diabetes care devices market is segmented into management devices (insulin pumps (technology and components (insulin pump devices, insulin pump reservoirs, and infusion sets)), insulin syringes, insulin pens (cartridges in reusable pens, disposable insulin pens), and jet injectors), and monitoring devices (self-monitoring blood glucose (glucometer devices, blood glucose test strips, and lancets) and continuous glucose monitoring (sensors and durables)) and End User ( Hospital/clinics, and Home/Personal). The report offers the value (in USD) and volume (in units) for the above segments.

Management Devices
Insulin Pump
Technology
Tethered Insulin Pump
Tubeless Insulin Pump
Component
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin pens
Cartridges in Reusable Pens
Insulin Disposable Pens
Insulin Syringes
Jet Injectors
Monitoring Devices
Self-monitoring Blood Glucose
Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring
Sensors
Durables (Receivers and Transmitters)
End User
Hospital/Clinics
Home/Personal
Need A Different Region Or Segment?
Customize Now

United Kingdom (UK) Diabetes Care Devices Market Size Summary

The United Kingdom diabetes care devices market is poised for significant growth over the forecast period, driven by an increasing prevalence of diabetes and the rising demand for innovative care solutions. The market has been influenced by the COVID-19 pandemic, which underscored the importance of remote and technology-driven diabetes care, leading to the removal of regulatory barriers and fostering interest in virtual consultations and diabetes technology. The growing incidence of Type 1 and Type 2 diabetes, largely attributed to factors such as obesity and sedentary lifestyles, is propelling the demand for diabetes care products. Continuous glucose monitoring (CGM) devices, in particular, are gaining traction due to advancements in technology that enhance accuracy and user-friendliness, with innovations like optical measurement and fluorescence sensing promising to further drive segment growth.

The market is characterized by a semi-consolidated landscape with key players such as Abbott, Medtronic, and Dexcom Inc. actively engaging in mergers, acquisitions, and partnerships to strengthen their market position. The introduction of insulin cartridges in reusable pens has also contributed to market expansion, offering a cost-effective and consumer-friendly alternative to traditional insulin delivery methods. Initiatives like the National Service Framework program and the Association of British HealthTech Industries' diabetes section are enhancing service quality and fostering collaboration among diabetes technology companies. Recent regulatory advancements, such as the National Institute of Clinical Excellence's inclusion of CGMs for children with Type 2 diabetes, highlight the ongoing shift towards more advanced and less invasive monitoring solutions, further supporting market growth.

Explore More

United Kingdom (UK) Diabetes Care Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Management Devices

      1. 2.1.1 Insulin Pump

        1. 2.1.1.1 Technology

          1. 2.1.1.1.1 Tethered Insulin Pump

          2. 2.1.1.1.2 Tubeless Insulin Pump

        2. 2.1.1.2 Component

          1. 2.1.1.2.1 Insulin Pump Device

          2. 2.1.1.2.2 Insulin Pump Reservoir

          3. 2.1.1.2.3 Infusion Set

      2. 2.1.2 Insulin pens

        1. 2.1.2.1 Cartridges in Reusable Pens

        2. 2.1.2.2 Insulin Disposable Pens

      3. 2.1.3 Insulin Syringes

      4. 2.1.4 Jet Injectors

    2. 2.2 Monitoring Devices

      1. 2.2.1 Self-monitoring Blood Glucose

        1. 2.2.1.1 Glucometer Devices

        2. 2.2.1.2 Blood Glucose Test Strips

        3. 2.2.1.3 Lancets

      2. 2.2.2 Continuous Glucose Monitoring

        1. 2.2.2.1 Sensors

        2. 2.2.2.2 Durables (Receivers and Transmitters)

    3. 2.3 End User

      1. 2.3.1 Hospital/Clinics

      2. 2.3.2 Home/Personal

United Kingdom (UK) Diabetes Care Devices Market Size FAQs

The United Kingdom Diabetes Care Devices Market size is expected to reach USD 84.31 million in 2024 and grow at a CAGR of 6.72% to reach USD 116.32 million by 2029.

In 2024, the United Kingdom Diabetes Care Devices Market size is expected to reach USD 84.31 million.

United Kingdom Diabetes Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)